Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Anerocid 300mg capsules

Ferron Par Pharmaceuticals

Product packaging may vary from one country to another.

Ingredients in every capsule

Clindamycin HCl 300 mg

Each package contains

5 strips of 6 capsules

Other details

Dosage formCapsule; hard
Flavour None

W.H.O. classification

ATC Level 1 J – Antiinfectives for systemic use
ATC Level 2 J01 – Antibacterials for Systemic Use
ATC Level 3 J01F – Macrolides; Lincosamides and Streptogramins

Warnings

Pregnancy

<span class="warning-1 warning-pregnancy">CAUTION</span>This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Dosage information

18 TO 65 YEARS OLD
— Serious infection:
150– 300 mg every 6 hours.

— More severe infection:
300-450 mg every six hours.

0 TO 18 YEARS OLD
3 – 6 mg/kg every 6 hours depending on the severity of the infection.

65 YEARS OLD AND ABOVE
Use with caution in elderly patients, changes in the frequency of bowel movements should be monitored due to elderly patients with severe diseases are sensitive to diarrhea.

ADMINISTRATION
— Antibiotic should be discontinued if diarrhea occurs during treatment.

— To prevent the possibility of esophageal irritation, clindamycin capsules should be administered orally with a full glass of water.

— For infections caused by β-hemolytic streptococci, treatment with clindamycin should be continued for at least 10 days.

PATIENT WITH HEPATIC OR RENAL FAILURE
In patient with hepatic or renal failure, dosage may be reduced due to in these patients prolonged half-life of the drug in serum.

Indication

For the treatment of severe infections caused by susceptible Gram-positive anaerobic organisms, such as streptococcus, pneumococcus and staphylococcus in :
– Respiratory tract infections: empysema, anaerobes pneumonitis, and lung abscess.
– Skin and soft tissue infections.
– Septicemia.
– Intra-abdominal infections, such as peritonitis and intra-abdominal abscess.
– Gynaecological infections, including endometritis, pelvic cellulitis, postsurgical vaginal infections.
– Bone and joint infections.